Provided by Tiger Fintech (Singapore) Pte. Ltd.

Bristol-Myers Squibb

43.45
-2.5300-5.50%
Volume:31.79M
Turnover:1.40B
Market Cap:88.42B
PE:16.27
High:45.51
Open:44.10
Low:42.96
Close:45.98
Loading ...
Feb 10, 2021

Major Issues Report

8-K - Current report
Feb 10, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 10, 2021

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 04, 2021

Major Issues Report

8-K - Current report
Feb 04, 2021

Major Issues Report

8-K - Current report
Feb 02, 2021

Major Issues Report

8-K - Current report
Jan 29, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 11, 2021

Major Issues Report

8-K - Current report
Jan 07, 2021

Delisting

25-NSE/A [Amend] - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
Jan 06, 2021

Correspondence

CORRESP [Cover] - Correspondence
Jan 04, 2021

Delisting

25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
Jan 04, 2021

Major Issues Report

8-K - Current report
Nov 17, 2020

Major Issues Report

8-K - Current report
Nov 13, 2020

Major Issues Report

8-K - Current report
Nov 10, 2020

[Supp]Public Prospectus

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
Nov 06, 2020

Major Issues Report

8-K - Current report
Nov 05, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 05, 2020

Major Issues Report

8-K - Current report
Oct 05, 2020

Major Issues Report

8-K - Current report
Aug 20, 2020

Major Issues Report

8-K - Current report